Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002
Conditions:
Hereditary Angioedema
Sponsor: Intellia Therapeutics
trial.available_in:
БГ
Overview
This is a follow-up study of subjects who received NTLA-2002 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Who can participate
Inclusion Criteria:
1. A subject has completed or discontinued from an Intellia-sponsored or -supported treatment protocol in which a complete or partial dose of NTLA-2002 was received.
2. A subject has provided informed consent for the LTFU study.
3. A subject is willing to attend study visits, complete protocol-required follow-up schedule, and comply with the study requirements.
Exclusion Criteria:
None
Locations
6
Australia (1)
Campbelltown Hospital
Campbelltown , New South Wales
France (1)
Centre National de Reference - Grenoble
Grenoble
Germany (1)
Charite-Universitätsmedizin Berlin
Berlin
Netherlands (1)
University of Amsterdam Academic Medical Center
Amsterdam
New Zealand (1)
New Zealand Clinical Research
Auckland
United Kingdom (1)
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
БГ